0 227

Cited 6 times in

Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use

Authors
 Lee, Sang Yeop  ;  Lee, Hun  ;  Bae, Hyoung Won  ;  Kim, Tae-im  ;  Kim, Chan Yun 
Citation
 OPTOMETRY AND VISION SCIENCE, Vol.93(10) : 1210-1217, 2016 
Journal Title
 OPTOMETRY AND VISION SCIENCE 
ISSN
 1040-5488 
Issue Date
2016
Keywords
topical anti-glaucoma medication ; tear film lipid layer thickness ; ocular surface disease ; LipiView interferometry
Abstract
PURPOSE: To investigate the effects of topical anti-glaucoma medications on tear lipid layer thickness (LLT) and the ocular surface. METHODS: This retrospective study examined ocular surface disease (OSD) subjects who had (n = 34) and who did not have (n = 51) open-angle glaucoma (OAG). OSD was evaluated with lipid layer thickness (using LipiView interferometer), tear breakup time (TBUT), total corneal and conjunctival staining (Oxford grading scale), and Ocular Surface Disease Index (OSDI). Four variables (total duration of anti-glaucoma medication use, duration of current anti-glaucoma medication use, total number of daily anti-glaucoma medication drops applied, and total number of anti-glaucoma medications [bottles]) related to anti-glaucoma medication were used to verify associations with LLT. RESULTS: Among the parameters, only LLT showed significantly lower values in the OAG group. In both groups, total staining showed a significant negative correlation between LLT and TBUT. Only in the OAG group, the OSDI showed significant correlations with number of medications (r = 0.389, p = 0.012) and daily number of drops (r = 0.354, p = 0.02); LLT showed significant correlations with TBUT (r = 0.381, p = 0.026) and total medication duration (r = -0.387, p = 0.013). In multivariate analyses, TBUT and total medication duration showed significant correlations with LLT (p = 0.032 and p = 0.015, respectively) in the OAG group. CONCLUSIONS: Topically medicated OAG subjects with OSD had a lower tear LLT than those with OSD who did not have OAG. Therefore, our results indicate that one should evaluate ocular surface disease status in patients who take anti-glaucoma medications.
Full Text
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00006324-201610000-00006&LSLINK=80&D=ovft
DOI
10.1097/OPX.0000000000000943
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Chan Yun(김찬윤) ORCID logo https://orcid.org/0000-0002-8373-9999
Kim, Tae Im(김태임) ORCID logo https://orcid.org/0000-0001-6414-3842
Bae, Hyoung Won(배형원) ORCID logo https://orcid.org/0000-0002-8421-5636
Lee, Sang Yeop(이상엽) ORCID logo https://orcid.org/0000-0002-3834-7953
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/153128
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse